background
novel
influenza
viru
subtyp
emerg
april
caus
first
influenza
pandem
centuri
reliabl
detect
differenti
season
influenza
virus
mandatori
appropri
case
manag
well
public
health
object
develop
technic
valid
novel
onestep
realtim
rtpcr
assay
use
influenza
viru
screen
subtyp
singleplex
fashion
assess
clinic
perform
novel
commerci
influenza
rtpcr
kit
base
inhous
version
studi
design
realtim
rtpcr
assay
target
matrix
gene
influenza
virus
develop
valid
use
vitro
transcrib
rna
deriv
influenza
viru
well
plaquequantifi
influenza
viru
sampl
valid
inhous
version
commerci
realstar
kit
use
assess
clinic
perform
specif
panel
influenza
virus
includ
swine
avian
well
patient
specimen
result
lower
limit
detect
inhous
version
rna
copiesml
respect
realstar
kit
display
sensit
specif
could
reliabl
discrimin
influenza
virus
cross
reaction
swine
observ
realstar
specif
probe
conclus
assay
demonstr
high
sensit
specif
might
assist
diagnosi
suspect
influenza
case
elsevi
bv
right
reserv
april
novel
influenza
viru
subtyp
emerg
caus
first
influenza
pandem
centuri
although
predomin
like
upcom
influenza
season
cocircul
season
influenza
subtyp
may
occur
definit
laboratori
diagnosi
remain
crucial
individu
patient
manag
well
epidemiolog
surveil
test
algorithm
includ
univers
screen
assay
influenza
viru
case
posit
result
typespecif
differenti
separ
assay
due
cumbersom
work
flow
high
cost
multiplex
assay
propos
simultan
screen
former
season
virus
howev
multiplex
pcr
reaction
gener
reduc
sensit
reliabl
addit
assay
far
avail
uniform
qualitycontrol
readytous
format
easili
adopt
clinic
laboratori
aim
studi
twofold
develop
matrix
genebas
realtim
rtpcr
allow
detect
season
influenza
simultan
assay
multiplex
assay
use
singl
amplicon
discrimin
respect
virus
accomplish
use
two
differ
fluoresc
probe
second
step
assay
transform
commerci
avail
homogen
test
kit
format
evalu
comprehens
panel
clinic
specimen
commerci
assay
use
oligonucleotid
inhous
version
includ
intern
control
system
monitor
possibl
inhibitori
substanc
procedur
failur
develop
valid
singleplex
realtim
rtpcr
assay
rapid
detect
simultan
differenti
influenza
viru
compar
limit
detect
inhous
assay
commerci
assay
base
inhous
version
evalu
commerci
kit
panel
clinic
sampl
upon
align
contemporari
sequenc
segment
variou
influenza
viru
subtyp
primer
probe
combin
select
manual
use
procedur
describ
univers
primer
pair
chosen
amplifi
bp
amplicon
two
specif
hydrolysi
probe
discrimin
influenza
viru
fig
reaction
condit
outlin
tabl
base
oligonucleotid
realstar
influenza
rtpcr
version
astra
diagnost
hamburg
germani
kit
develop
use
proprietari
technolog
commerci
assay
contain
l
rna
sampl
total
reaction
volum
l
intern
heterolog
control
system
includ
monitor
possibl
inhibitori
effect
sampl
matrix
compris
exogen
spike
rna
low
copi
number
realstar
kit
perform
abi
prism
realtim
cycler
appli
biosystem
weiterstadt
germani
major
clinic
specimen
nasopharyng
swab
univers
transport
medium
copan
brescia
itali
bronchoalveolar
lavag
fluid
rna
extract
viral
rna
mini
kit
l
input
l
elut
volum
qiagen
hilden
germani
determin
lower
limit
detect
lod
inhous
assay
plaquequantifi
influenza
cell
cultur
supernat
well
vitro
rna
transcript
partial
segment
spike
viral
transport
medium
extract
process
describ
influenza
partial
fragment
matrix
gene
amplifi
use
primer
respect
invitro
rna
transcript
construct
describ
crossreact
inhous
assay
test
panel
respiratori
sampl
contain
adenoviru
n
respiratori
syncyti
virusa
n
respiratori
syncyti
virusb
n
human
coronavirus
n
n
n
human
metapneumoviru
n
parainfluenzaviru
n
parainfluenzaviru
n
enterorhinovirus
n
addit
sampl
neg
respiratori
viru
also
analyz
inhous
assay
store
influenza
viru
posit
patient
sampl
includ
sampl
reanalyz
inhous
assay
specif
also
test
season
influenza
pcr
posit
sampl
addit
realstar
kit
evalu
panel
influenza
viru
cell
cultur
supernat
includ
classic
swine
influenza
panel
previous
quantifi
patient
specimen
first
step
use
vitro
transcrib
rna
assess
linear
rang
inhous
assay
tenfold
serial
dilut
test
triplic
linear
relationship
observ
least
copi
per
reaction
influenza
respect
data
shown
pcr
effici
calcul
respect
accord
pcr
amplif
formula
tabl
oligonucleotid
singleplex
realtim
rtpcr
assay
e
e
pcr
effici
next
vitro
transcrib
rna
use
determin
limit
detect
lod
use
probit
analysi
tabl
influenza
viru
panel
rang
differ
rna
target
concentr
use
cycl
threshold
c
valu
accordingli
store
influenza
viru
posit
patient
sampl
includ
sampl
yield
posit
result
inhous
assay
lod
realstar
kit
assess
use
plaquequantifi
influenza
viru
tenfold
limit
dilut
seri
test
triplic
least
pfuml
detect
assay
render
equal
sensit
data
shown
correspondingli
lod
determin
use
vitro
transcrib
rna
lod
ci
ci
ci
rna
copiesml
influenza
season
influenza
determin
respect
panel
differ
influenza
viru
subtyp
includ
swine
yield
fluoresc
signal
probe
posit
univers
influenza
viru
probe
furthermor
season
influenza
posit
sampl
correctli
identifi
realstar
assay
tabl
similar
inhous
version
even
low
concentr
sampl
detect
note
c
valu
obtain
realstar
kit
gener
lower
obtain
inhous
version
refer
assay
might
part
reflect
higher
sampl
input
volum
kit
final
posit
patient
sampl
reevalu
realstar
kit
yield
concord
result
c
valu
specif
rtpcr
rang
mean
realstar
kit
mean
respect
p
pair
ttest
intern
control
yield
valid
reaction
sampl
demonstr
robust
assay
describ
matrix
genebas
assay
simultan
detect
influenza
virus
differenti
singleplex
fashion
uniformli
good
overal
sensit
analyt
sensit
inhous
version
compar
publish
singleplex
rtpcr
assay
first
time
lod
contemporari
human
influenza
virus
thoroughli
assess
technic
standpoint
addit
describ
evalu
one
first
commerci
test
kit
specif
design
meet
demand
current
pandem
realstar
kit
render
even
sensit
inhous
assay
like
attribut
higher
sampl
input
volum
equal
specif
particularli
panel
origin
patient
sampl
realstar
kit
show
superior
perform
wide
use
realtim
rtpcr
detect
low
concentr
sampl
may
becom
import
eg
monitor
viru
concentr
patient
treat
oseltamivir
midst
epidem
rapid
provis
readytous
test
kit
signific
impact
perform
laboratori
although
hous
diagnost
test
design
implement
outstand
rapid
frontlin
laboratori
may
lack
capac
implement
assay
avail
readytous
system
might
therefor
assist
laboratori
patient
manag
surveil
combin
rapid
intern
control
system
qualiti
control
reagent
approach
might
use
gener
public
health
laboratori
conclus
assay
demonstr
use
current
pandem
might
assist
laboratori
provid
result
time
standard
cost
effect
manner
